Organisms | Evidence |
---|---|
Ovis aries (sheep) | |
Cricetulus griseus (Chinese hamster) | |
Mus musculus (house mouse) | |
Bos taurus (domestic cattle) | |
Escherichia coli |
Gene Symbol | Donor | Acceptor | Reducing terminal(Acceptor) | Product | Reducing terminal(Product) | Reference |
---|---|---|---|---|---|---|
C1GALT1 | (not applicable) |
|
Ser/Thr |
|
Ser/Thr | |
ST6GALNAC1 | CMP-Neu5Ac |
|
Ser/Thr |
|
Ser/Thr | |
ST6GALNAC1 | CMP-Neu5Ac |
|
O-glycan Synthesis |
|
O-glycan Synthesis | |
B3GNT6 | UDP-GlcNAc |
|
[alpha]-pNP |
|
[alpha]-pNP |
Gene Symbol | Donor | Acceptor | Reducing terminal(Acceptor) | Product | Reducing terminal(Product) | Reference |
---|---|---|---|---|---|---|
C1GALT1 | (not applicable) |
|
Ser/Thr |
|
Ser/Thr | |
ST6GALNAC1 | CMP-Neu5Ac |
|
Ser/Thr |
|
Ser/Thr | |
ST6GALNAC4 | CMP-Neu5Ac |
|
benzyl |
|
benzyl | |
ST6GALNAC1 | CMP-Neu5Ac |
|
O-glycan Synthesis |
|
O-glycan Synthesis | |
ST6GALNAC1 | CMP-Neu5Ac |
|
[Ala-Thr(*)-Ala]2-7 |
|
[Ala-Thr(*)-Ala]2-7 |
Gene Symbol | Donor | Acceptor | Reducing terminal(Acceptor) | Reference |
---|---|---|---|---|
ST6GALNAC3 | CMP-Neu5Ac |
|
Ser/Thr | |
ST6GAL2 | CMP-Neu5Ac |
|
para-nitrophenol | |
ST6GALNAC2 | CMP-Neu5Ac |
|
benzyl | |
ST6GALNAC1 | CMP-Neu5Ac |
|
[alpha]-Bz | |
ST6GALNAC2 | CMP-Neu5Ac |
|
Ser/Thr |
UniProt ID | Protein Name | Reference | Source |
---|---|---|---|
O15240 | Neurosecretory protein VGF | ||
O15354 | Prosaposin receptor GPR37 | ||
O15533 | Tapasin | ||
O43157 | Plexin-B1 | ||
O43278 | Kunitz-type protease inhibitor 1 | ||
O43286 | Beta-1,4-galactosyltransferase 5 | ||
O43291 | Kunitz-type protease inhibitor 2 | ||
O43405 | Cochlin | ||
O43493 | Trans-Golgi network integral membrane protein 2 | ||
O43529 | Carbohydrate sulfotransferase 10 |
Pathway Name | Organism |
---|---|
Lectin pathway of complement activation | Sus scrofa |
Lectin pathway of complement activation | Canis familiaris |
Lectin pathway of complement activation | Xenopus tropicalis |
Lectin pathway of complement activation | Rattus norvegicus |
Lectin pathway of complement activation | Homo sapiens |
Lectin pathway of complement activation | Mus musculus |
Lectin pathway of complement activation | Gallus gallus |
RES 1b:a-dgal-HEX-1:5 2s:n-acetyl LIN 1:1d(2+1)2n
PubMed ID | Title | First Author | Publication Date | Source |
---|---|---|---|---|
30570431 | Integrated Assessment of the Clinical Performance of GalNAc3-Conjugated 2′-O-Methoxyethyl Chimeric Antisense Oligonucleotides: I. Human Volunteer Experience | Crooke ST | 2019 Feb |
|
31891487 | An N-Acetylgalactosamino Dendron-Clearing Agent for High-Therapeutic-Index DOTA-Hapten Pretargeted Radioimmunotherapy | Cheal SM | 2019 Dec 31 |
|
31792921 | Leading RNA Interference Therapeutics Part 2: Silencing Delta-Aminolevulinic Acid Synthase 1, with a Focus on Givosiran | de Paula Brandão PR | 2019 Dec 02 |
|
31491467 | Structural basis of the pH-dependent conformational change of the N-terminal region of human mannose receptor/CD206 | Hu Z | 2019 Dec 01 |
|
31373799 | Engineering Orthogonal Polypeptide GalNAc-Transferase and UDP-Sugar Pairs | Choi J | 2019 Aug 02 |
|
31374852 | Galactosaminoglycans: Medical Applications and Drawbacks | Pomin VH | 2019 Aug 01 |
|
31102718 | Current and innovative emerging therapies for porphyrias with hepatic involvement | Fontanellas A | 2019 Aug |
|
30934149 | N‐Acetyl‐<scp>d</scp>‐galactosamine prevents soya bean agglutinin‐induced intestinal barrier dysfunction in intestinal porcine epithelial cells | Zhao B | 2019 Apr |
|
30611426 | The Preparation and Solution NMR Spectroscopy of Human Glycoproteins Is Accessible and Rewarding | Barb AW | 2019 |
|
30204301 | Multiplexed Metabolic Labeling of Glycoconjugates in Polarized Primary Cerebral Cortical Neurons | Choi JY | 2018 Sep 26 |
|
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
This work is licensed under Creative Commons Attribution 4.0 International
GlyCosmos Portal v4.2.1
Last updated: April 7, 2025